IMA Advisory Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240 Hold
3
﹤0.01% 945
2025
Q4
$255 Hold
3
﹤0.01% 921
2025
Q3
$233 Hold
3
﹤0.01% 480
2025
Q2
$235 Buy
+3
New +$224 ﹤0.01% 463
2023
Q4
Sell
-42
Closed -$2.91K 124
2023
Q3
$2.91K Hold
42
﹤0.01% 264
2023
Q2
$3.96K Hold
42
﹤0.01% 268
2023
Q1
$3.48K Hold
42
﹤0.01% 271
2022
Q4
$3.13K Hold
42
﹤0.01% 299
2022
Q3
$3K Hold
42
﹤0.01% 289
2022
Q2
$4K Hold
42
﹤0.01% 287
2022
Q1
$5K Hold
42
﹤0.01% 267
2021
Q4
$5K Hold
42
﹤0.01% 278
2021
Q3
$5K Hold
42
﹤0.01% 257
2021
Q2
$4K Hold
42
﹤0.01% 259
2021
Q1
$4K Hold
42
﹤0.01% 266
2020
Q4
$4K Sell
42
-15
-26% -$1.24K ﹤0.01% 258
2020
Q3
$5K Buy
57
+15
+36% +$1.17K ﹤0.01% 231
2020
Q2
$3K Hold
42
﹤0.01% 235
2020
Q1
$3K Hold
42
﹤0.01% 237
2019
Q4
$3K Sell
42
-81
-66% -$6.33K ﹤0.01% 265
2019
Q3
$9K Hold
123
﹤0.01% 213
2019
Q2
$8K Buy
123
+81
+193% +$4.9K ﹤0.01% 208
2019
Q1
$3K Sell
42
-150
-78% -$8.56K ﹤0.01% 254
2018
Q4
$10K Hold
192
﹤0.01% 221
2018
Q3
$11K Sell
192
-75
-28% -$3.67K ﹤0.01% 218
2018
Q2
$13K Buy
+267
New +$12.5K 0.01% 246

Other funds holding EW

IMA Advisory Services's EW Position: Q1 2026 in Review

IMA Advisory Services held its Edwards Lifesciences (EW) position steady in Q1 2026 at 3 shares worth $240. The position accounts for ﹤0.01% of the portfolio, ranked #945.

IMA Advisory Services first reported a position in EW in Q2 2018 and has held it in 26 quarters since. The position peaked at $13K in Q2 2018. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • IMA Advisory Services held 3 shares of Edwards Lifesciences worth $240 as of Q1 2026.
  • IMA Advisory Services left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of IMA Advisory Services's portfolio in Q1 2026, its #945 holding.
  • IMA Advisory Services first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 26 quarters since.
  • IMA Advisory Services's Edwards Lifesciences position peaked at $13K in Q2 2018.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.